-TheWire.in A Tata Nano pays the same toll to go from Mumbai and Pune on the expressway as does a Rolls Royce. Why should pharmaceutical products be any different? On May 26, amid news reports about yet another closed-door meeting that the National Pharmaceutical Pricing Authority (NPPA) had had with unspecified stakeholders, we were reminded of an interesting press release that the Ministry of Chemicals and Fertilisers had issued in July 2021. The...
More »SEARCH RESULT
Total Matching Records found : 85
800-plus essential drugs to increase by 10.7 per cent from Friday -Kavita Bajeli-Datt
-The New Indian Express These scheduled medicines constitute about 18 per cent of the total domestic pharma retail market, valued around Rs 1.5 trillion. NEW DELHI: Prices of over 800 drugs under the National List of Essential Medicines (NLEM), including paracetamol, common antibiotics like azithromycin, doxycycline and medications for hypertension, diabetes and COVID-19 will increase by 10.7 per cent starting Friday. Activists slammed the move saying that it would hit the pockets of...
More »India learns a bitter lesson for disregarding crucial warnings and recommendations on Covid-19
In the month of April this year, there has been an unprecedented upsurge in daily new cases and daily new deaths in the country due to Covid-19. States, which reported large increases in daily new cases and daily new deaths, are Maharashtra, Kerala, Karnataka, Delhi and Uttar Pradesh, to name but a few. Data accessed from https://www.covid19india.org/, which is a crowdsourced platform and an independent aggregator of daily Covid-19 figures and...
More »Almost 90% slash in prices of nine anti-cancer drugs -Pushpa Narayan
-The Times of India CHENNAI: In a major step to make cancer cure affordable for patients and their families, the retail prices of several anti-cancer drugs, including commonly used chemotherapy injections for lung cancer treatment, have been slashed by up to 87% by the drug price control authority. After reviewing the data collected from drug manufacturers, the National Pharmaceutical Pricing Authority’s May 15 memorandum has brought nine anti-cancer drugs in its price...
More »Holes in cancer drug price cap -GS Mudur
-The Telegraph Call to govt to adopt 'cost-based' control The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices remain “prohibitive”, a network of patients’ rights groups said on Saturday. The All India Drug Action Network (Aidan) said the National Pharmaceutical Pricing Authority’s cap on profit margins in effect “legitimises” the...
More »
